When Christopher Denny went for his annual check-up in February 2022, he expected a clean bill of health. Instead, his ...
Jesse Bennett, a two-time prostate cancer survivor and Morgan State University health education graduate, uses his journey to inspire other men to take charge of their health by learning their PSA ...
Luton Today on MSN
Luton blood testing for prostate cancer on 22nd November
Luton Someries Rotary Club has organised and subsidised a prostate cancer blood test ('PSA') clinic for men aged 40 years+ on ...
AIIMS radiologist stresses importance of early prostate cancer screening, starting at age 50, or earlier for those with risk ...
VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 ...
VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...
ZME Science on MSN
A Simple Urine Test Detects Prostate Cancer with Remarkable Accuracy
Scientists use a metric called “area under the curve” or AUC to assess how well the test performed. An AUC of 1 is a perfect ...
Prostate cancer is the malignant growth of cells in the prostate, a walnut-sized gland below the bladder, that is responsible for producing semen. The majority of prostate cancers develop at a slow ...
The media frenzy surrounding former President Joe Biden’s metastatic prostate cancer diagnosis last May didn’t faze one Lancaster resident. Doctors and politicians debated whether Biden and his ...
Patients with D2T-PsA can be stratified into inflammatory and noninflammatory phenotypes, with the former linked to higher sonographic activity.
SurvivorNet on MSN
A True Game-Changer in Prostate Cancer: A Simple Genomic Test Can Tell Us Who Needs Hormone Therapy And Who Doesn’t
How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...
The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results